Kbc Group Nv Merck & Co., Inc. Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kbc Group Nv holds 2,616,262 shares of MRK stock, worth $234 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

2,616,262

Previous 2,481,859 5.42%

Holding current value

$234 Million

Previous $282 Million 7.65%

% of portfolio

0.72%

Previous 0.85%

45 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$96.31 - $114.76 $12.9 Million - $15.4 Million	134,403 Added 5.42%	2,616,262 $260 Million
Q3 2024 Nov 06, 2024	SELL	$111.15 - $128.97 $98.3 Million - $114 Million	-884,248 Reduced 26.27%	2,481,859 $282 Million
Q2 2024 Jul 17, 2024	BUY	$123.8 - $132.96 $121 Million - $130 Million	978,655 Added 40.99%	3,366,107 $417 Million
Q1 2024 May 08, 2024	SELL	$113.24 - $131.95 $982,357 - $1.14 Million	-8,675 Reduced 0.36%	2,387,452 $315 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $61.7 Million - $67.1 Million	615,721 Added 34.58%	2,396,127 $261 Million
Q3 2023 Feb 15, 2024	BUY	$102.95 - $114.33 $42.4 Million - $47.1 Million	412,320 Added 23.07%	2,199,619 $226 Million
Q2 2023 Feb 15, 2024	SELL	$108.61 - $118.38 $17.9 Million - $19.6 Million	-165,210 Reduced 8.46%	1,787,299 $206 Million
Q2 2023 Jul 28, 2023	SELL	$108.61 - $118.38 $8.9 Million - $9.71 Million	-81,985 Reduced 4.4%	1,780,406 $205 Million
Q1 2023 Feb 14, 2024	SELL	$102.94 - $114.86 $53.6 Million - $59.8 Million	-520,820 Reduced 21.77%	1,871,314 $199 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $8.88 Million - $9.91 Million	-86,289 Reduced 4.43%	1,862,391 $198 Million
Q4 2022 Feb 14, 2024	BUY	$87.44 - $112.11 $35.3 Million - $45.3 Million	403,890 Added 20.31%	2,392,134 $265 Million
Q3 2022 Feb 15, 2024	SELL	$84.53 - $94.96 $37.5 Million - $42.1 Million	-443,618 Reduced 18.51%	1,952,509 $168 Million
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $896,018 - $1.01 Million	-10,600 Reduced 0.54%	1,948,680 $168 Million
Q2 2022 Feb 14, 2024	BUY	$83.49 - $94.64 $103 Million - $116 Million	1,230,521 Added 162.4%	1,988,244 $181 Million
Q2 2022 Jul 26, 2022	BUY	$83.49 - $94.64 $100 Million - $114 Million	1,201,557 Added 158.57%	1,959,280 $179 Million
Q1 2022 Feb 14, 2024	SELL	$73.51 - $82.4 $65 Million - $72.8 Million	-883,835 Reduced 53.84%	757,723 $62.2 Million
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $65 Million - $72.8 Million	-883,835 Reduced 53.84%	757,723 $62.2 Million
Q4 2021 Feb 14, 2024	SELL	$72.28 - $90.54 $54.5 Million - $68.3 Million	-754,569 Reduced 31.49%	1,641,558 $126 Million
Q4 2021 Feb 03, 2022	BUY	$72.28 - $90.54 $19 Million - $23.8 Million	262,944 Added 19.07%	1,641,558 $126 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $90.8 Million - $99.8 Million	-1,266,108 Reduced 47.87%	1,378,614 $104 Million
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $12.2 Million - $13.5 Million	173,670 Added 7.03%	2,644,722 $206 Million
Q1 2021 Apr 26, 2021	SELL	$68.86 - $81.11 $17.4 Million - $20.5 Million	-252,921 Reduced 9.29%	2,471,052 $190 Million
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $25.8 Million - $28.7 Million	360,045 Added 15.23%	2,723,973 $223 Million
Q3 2020 Oct 28, 2020	SELL	$73.18 - $82.95 $7.03 Million - $7.97 Million	-96,065 Reduced 3.91%	2,363,928 $196 Million
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $3.76 Million - $4.28 Million	-53,368 Reduced 2.12%	2,459,993 $190 Million
Q1 2020 May 04, 2020	BUY	$63.36 - $87.82 $9.51 Million - $13.2 Million	150,087 Added 6.35%	2,513,361 $193 Million
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $1.33 Million - $1.5 Million	17,152 Added 0.73%	2,363,274 $215 Million
Q3 2019 Nov 07, 2019	BUY	$76.08 - $82.93 $178 Million - $194 Million	2,343,032 Added 75826.28%	2,346,122 $188 Million
Q2 2019 Dec 03, 2019	SELL	$69.84 - $81.59 $147 Million - $172 Million	-2,103,742 Reduced 99.85%	3,090 $259,000
Q2 2019 Jul 30, 2019	BUY	$69.84 - $81.59 $147 Million - $172 Million	2,103,742 Added 68082.27%	2,106,832 $0
Q1 2019 Dec 03, 2019	SELL	$69.58 - $79.36 $124 Million - $141 Million	-1,775,841 Reduced 99.83%	3,090 $257,000
Q1 2019 May 10, 2019	BUY	$69.58 - $79.36 $124 Million - $141 Million	1,775,841 Added 57470.58%	1,778,931 $0
Q4 2018 Dec 03, 2019	SELL	$65.24 - $75.71 $63.5 Million - $73.7 Million	-973,297 Reduced 99.68%	3,090 $236,000
Q4 2018 Jan 31, 2019	BUY	$65.24 - $75.71 $63.5 Million - $73.7 Million	973,297 Added 31498.28%	976,387 $71.2 Million
Q3 2018 Dec 03, 2019	SELL	$57.69 - $67.84 $68 Million - $80 Million	-1,178,538 Reduced 99.74%	3,090 $219,000
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $68 Million - $80 Million	1,178,538 Added 38140.39%	1,181,628 $0
Q2 2018 Dec 03, 2019	SELL	$50.83 - $59.72 $59.5 Million - $69.9 Million	-1,170,890 Reduced 99.74%	3,090 $188,000
Q2 2018 Aug 03, 2018	BUY	$50.83 - $59.72 $59.5 Million - $69.9 Million	1,170,890 Added 37892.88%	1,173,980 $0
Q1 2018 Dec 03, 2019	SELL	$50.96 - $59.23 $64.5 Million - $75 Million	-1,266,236 Reduced 99.76%	3,090 $168,000
Q1 2018 May 09, 2018	BUY	$50.96 - $59.23 $64.5 Million - $74.9 Million	1,264,936 Added 28814.03%	1,269,326 $0
Q4 2017 Dec 03, 2019	SELL	$51.62 - $61.64 $87.4 Million - $104 Million	-1,693,647 Reduced 99.74%	4,390 $247,000
Q4 2017 Feb 07, 2018	BUY	$51.62 - $61.64 $87.4 Million - $104 Million	1,693,647 Added 38579.66%	1,698,037 $0
Q3 2017 Dec 03, 2019	SELL	$58.67 - $63.13 $116 Million - $125 Million	-1,973,786 Reduced 99.78%	4,390 $281,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $116 Million - $125 Million	1,973,786 Added 44960.96%	1,978,176 $0
Q2 2017 Dec 03, 2019	BUY	N/A	4,390	4,390 $281,000

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account